デフォルト表紙
市場調査レポート
商品コード
1151567

世界の末梢血市場:産業調査報告書、成長動向と競合分析 (2022年~2028年)

Global Peripheral Blood Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

出版日: | 発行: QYResearch | ページ情報: 英文 87 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の末梢血市場:産業調査報告書、成長動向と競合分析 (2022年~2028年)
出版日: 2022年11月11日
発行: QYResearch
ページ情報: 英文 87 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、末梢血 (Peripheral Blood) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査対象範囲
  • 市場 セグメントタイプ別
    • 世界の末梢血の市場規模成長率:タイプ別 (2017 VS 2021 VS 2028)
    • Leukopak
    • Stem Cells
    • PBMCs
    • Others
  • 市場セグメント:用途別
    • 世界の末梢血の市場シェア:用途別 (2017 VS 2021 VS 2028)
    • Disease Treatment
    • Research and Development
    • Other
  • 調査目的
  • 対象期間

第2章 市場展望

  • 世界の末梢血 市場規模 (2017-2028)
    • 世界の末梢血の収益 (2017-2028)
    • 世界の末梢血 売上 (2017-2028)
  • 世界の末梢血 世界の主要地域における市場規模: 2017 VS 2021 VS 2028
    • 世界の末梢血 販売:地域別 (2017-2022)
    • 世界の末梢血 収益:地域別 (2017-2022)
  • 世界の末梢血 市場規模予測:地域別
    • 世界の末梢血の販売予測:地域別 (2023-2028)
    • 世界の末梢血の収益予測:地域別 (2023-2028)
  • 世界のトップ 末梢血 地域(国) ランキング別 市場規模
  • 末梢血 市場動向
    • 末梢血 市場トレンド
    • 末梢血 市場の促進要因
    • 末梢血 市場の課題
    • 末梢血 市場の抑制要因

第3章 競争状況:企業別

  • 世界のトップ 末梢血の上位企業:販売別 (2017-2022)
    • 世界の末梢血の販売:企業別 (2017-2022)
    • 世界の末梢血の販売市場シェア:企業別 (2017-2022)
    • 世界の5大・10大企業 末梢血 売上2021
  • 世界のトップ 企業 末梢血 収益別
    • 世界の末梢血の収益:企業別 (2017-2022)
    • トップ 末梢血 企業:収益別ランキング
    • 世界の末梢血の収益シェア:企業別 (2017-2022)
    • 世界の末梢血 市場集中度 (CR5 ・ HHI)
  • 世界のトップ 企業 企業タイプ別 (Tier 1, Tier 2 ・ Tier 3) & (売上高に基づいた末梢血 (2021年時点))
  • 世界の末梢血 企業別平均販売価格(ASP)
  • 主要企業 末梢血 工場・事業所分布と供給地域
  • 主要企業の参入時期 末梢血 市場
  • 主要企業 末梢血 取扱商品
  • M&A, 拡張計画

第4章 世界の末梢血 市場規模:タイプ別

  • 世界の末梢血の過去の市場概要:タイプ別 (2017-2022)
    • 世界の末梢血の販売市場シェア:タイプ別 (2017-2022)
    • 世界の末梢血の収益市場シェア:タイプ別 (2017-2022)
    • 末梢血の価格:タイプ別 (2017-2022)
  • 世界の末梢血の市場 推定および予測:タイプ別 (2023-2028)
    • 世界の末梢血の販売予測:タイプ別 (2023-2028)
    • 世界の末梢血の収益予測:タイプ別 (2023-2028)
    • 末梢血の価格予測:タイプ別 (2023-2028)

第5章 世界の末梢血 市場規模:用途別

  • 世界の末梢血の過去の市場概要:用途別 (2017-2022)
    • 世界の末梢血の販売市場シェア:用途別 (2017-2022)
    • 世界の末梢血の収益市場シェア:用途別 (2017-2022)
    • 末梢血の価格:用途別 (2017-2022)
  • 世界の末梢血の市場 推定および予測:用途別 (2023-2028)
    • 世界の末梢血の販売予測:用途別 (2023-2028)
    • 世界の末梢血の収益予測:用途別 (2023-2028)
    • 末梢血の価格予測:用途別 (2023-2028)

第6章 北米

  • 北米の末梢血 売上内訳:企業別
    • 北米の末梢血 売上:企業別 (2017-2022)
    • 北米の末梢血 収益:企業別 (2017-2022)
  • 北米の末梢血 市場規模:タイプ別
    • 北米の末梢血の販売:タイプ別 (2017-2028)
    • 北米の末梢血の収益:タイプ別 (2017-2028)
  • 北米の末梢血 市場規模:用途別
    • 北米の末梢血の販売:用途別 (2017-2028)
    • 北米の末梢血の収益:用途別 (2017-2028)
  • 北米の末梢血 市場規模:国別
    • 北米の末梢血の販売:国別 (2017-2028)
    • 北米の末梢血の収益:国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の末梢血 売上内訳:企業別
    • 欧州の末梢血 売上:企業別 (2017-2022)
    • 欧州の末梢血 収益:企業別 (2017-2022)
  • 欧州の末梢血 市場規模:タイプ別
    • 欧州の末梢血の販売:タイプ別 (2017-2028)
    • 欧州の末梢血の収益:タイプ別 (2017-2028)
  • 欧州の末梢血 市場規模:用途別
    • 欧州の末梢血の販売:用途別 (2017-2028)
    • 欧州の末梢血の収益:用途別 (2017-2028)
  • 欧州の末梢血 市場規模:国別
    • 欧州の末梢血の販売:国別 (2017-2028)
    • 欧州の末梢血の収益:国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の末梢血 売上内訳:企業別
    • アジア太平洋の末梢血 売上:企業別 (2017-2022)
    • アジア太平洋の末梢血 収益:企業別 (2017-2022)
  • アジア太平洋の末梢血 市場規模:タイプ別
    • アジア太平洋の末梢血の販売:タイプ別 (2017-2028)
    • アジア太平洋の末梢血の収益:タイプ別 (2017-2028)
  • アジア太平洋の末梢血 市場規模:用途別
    • アジア太平洋の末梢血の販売:用途別 (2017-2028)
    • アジア太平洋の末梢血の収益:用途別 (2017-2028)
  • アジア太平洋の末梢血 市場規模:地域別
    • アジア太平洋の末梢血の販売:地域別
    • アジア太平洋の末梢血の収益:地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン
    • ベトナム

第9章 ラテンアメリカ

  • ラテンアメリカの末梢血 売上内訳:企業別
    • ラテンアメリカの末梢血 売上:企業別 (2017-2022)
    • ラテンアメリカの末梢血 収益:企業別 (2017-2022)
  • ラテンアメリカの末梢血 市場規模:タイプ別
    • ラテンアメリカの末梢血の販売:タイプ別 (2017-2028)
    • ラテンアメリカの末梢血の収益:タイプ別 (2017-2028)
  • ラテンアメリカの末梢血 市場規模:用途別
    • ラテンアメリカの末梢血の販売:用途別 (2017-2028)
    • ラテンアメリカの末梢血の収益:用途別 (2017-2028)
  • ラテンアメリカの末梢血 市場規模:国別
    • ラテンアメリカの末梢血の販売:国別 (2017-2028)
    • ラテンアメリカの末梢血の収益:国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの末梢血 売上内訳:企業別
    • 中東・アフリカの末梢血 売上:企業別 (2017-2022)
    • 中東・アフリカの末梢血 収益:企業別 (2017-2022)
  • 中東・アフリカの末梢血 市場規模:タイプ別
    • 中東・アフリカの末梢血の販売:タイプ別 (2017-2028)
    • 中東・アフリカの末梢血の収益:タイプ別 (2017-2028)
  • 中東・アフリカの末梢血 市場規模:用途別
    • 中東・アフリカの末梢血の販売:用途別 (2017-2028)
    • 中東・アフリカの末梢血の収益:用途別 (2017-2028)
  • 中東・アフリカの末梢血 市場規模:国別
    • 中東・アフリカの末梢血の販売:国別 (2017-2028)
    • 中東・アフリカの末梢血の収益:国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • U.A.E

第11章 企業プロファイル

  • HemaCare
  • StemExpress
  • AllCells
  • Mozobil

第12章 バリューチェーンと販売チャネルの分析

  • 末梢血 バリューチェーンの分析
  • 末梢血 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 末梢血 生産形態とプロセス
  • 末梢血 販売およびマーケティング
    • 末梢血 販売チャネル
    • 末梢血 卸業者
  • 末梢血 顧客

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

  • Table 1. Global Peripheral Blood Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Leukopak
  • Table 3. Major Manufacturers of Stem Cells
  • Table 4. Major Manufacturers of PBMCs
  • Table 5. Major Manufacturers of Others
  • Table 6. Global Peripheral Blood Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Peripheral Blood Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
  • Table 8. Global Peripheral Blood Sales by Region (2017-2022) & (K Units)
  • Table 9. Global Peripheral Blood Sales Market Share by Region (2017-2022)
  • Table 10. Global Peripheral Blood Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Peripheral Blood Revenue Market Share by Region (2017-2022)
  • Table 12. Global Peripheral Blood Sales Forecast by Region (2023-2028) & (K Units)
  • Table 13. Global Peripheral Blood Sales Market Share Forecast by Region (2023-2028)
  • Table 14. Global Peripheral Blood Revenue Forecast by Region (2023-2028) & (US$ Million)
  • Table 15. Global Peripheral Blood Revenue Market Share Forecast by Region (2023-2028)
  • Table 16. Top Peripheral Blood Regions (Countries) Ranking by Market Size (US$ Million) in 2021
  • Table 17. Peripheral Blood Market Trends
  • Table 18. Peripheral Blood Market Drivers
  • Table 19. Peripheral Blood Market Challenges
  • Table 20. Peripheral Blood Market Restraints
  • Table 21. Global Peripheral Blood Sales by Manufacturers (2017-2022) & (K Units)
  • Table 22. Global Peripheral Blood Sales Share by Manufacturers (2017-2022)
  • Table 23. Global Peripheral Blood Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 24. Ranking of Global Top Peripheral Blood Manufacturers by Revenue (US$ Million) in 2021
  • Table 25. Peripheral Blood Revenue Share by Manufacturers (2017-2022)
  • Table 26. Global Peripheral Blood Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Blood as of 2021)
  • Table 28. Key Manufacturers Peripheral Blood Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
  • Table 29. Key Manufacturers Peripheral Blood Plants/Factories Distribution
  • Table 30. Key Manufacturers Peripheral Blood Area Served
  • Table 31. Date of Key Manufacturers Enter into Peripheral Blood Market
  • Table 32. Key Manufacturers Peripheral Blood Product Type
  • Table 33. Mergers & Acquisitions, Expansion Plans
  • Table 34. Global Peripheral Blood Sales (K Units) by Type (2017-2022)
  • Table 35. Global Peripheral Blood Sales Share by Type (2017-2022)
  • Table 36. Global Peripheral Blood Revenue (US$ Million) Market Share by Type (2017-2022)
  • Table 37. Global Peripheral Blood Price (K Units) by Type (2017-2022)
  • Table 38. Global Peripheral Blood Sales (K Units) by Type (2023-2028)
  • Table 39. Global Peripheral Blood Sales Share by Type (2023-2028)
  • Table 40. Global Peripheral Blood Revenue (US$ Million) Market Share by Type (2023-2028)
  • Table 41. Global Peripheral Blood Revenue Share by Type (2023-2028)
  • Table 42. Global Peripheral Blood Price (K Units) by Type (2023-2028)
  • Table 43. Global Peripheral Blood Sales (K Units) by Application (2017-2022)
  • Table 44. Global Peripheral Blood Sales Share by Application (2017-2022)
  • Table 45. Global Peripheral Blood Revenue (US$ Million) Market Share by Application (2017-2022)
  • Table 46. Global Peripheral Blood Price (K Units) by Application (2017-2022)
  • Table 47. Global Peripheral Blood Sales (K Units) by Application (2023-2028)
  • Table 48. Global Peripheral Blood Sales Share by Application (2023-2028)
  • Table 49. Global Peripheral Blood Revenue (US$ Million) Market Share by Application (2023-2028)
  • Table 50. Global Peripheral Blood Revenue Share by Application (2023-2028)
  • Table 51. Global Peripheral Blood Price (K Units) by Application (2023-2028)
  • Table 52. North America Peripheral Blood Sales by Company (2017-2022) & (K Units)
  • Table 53. North America Peripheral Blood Sales Market Share by Company (2017-2022)
  • Table 54. North America Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
  • Table 55. North America Peripheral Blood Revenue Market Share by Company (2017-2022)
  • Table 56. North America Peripheral Blood Sales by Type (2017-2022) & (K Units)
  • Table 57. North America Peripheral Blood Sales by Type (2023-2028) & (K Units)
  • Table 58. North America Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
  • Table 59. North America Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
  • Table 60. North America Peripheral Blood Sales by Application (2017-2022) & (K Units)
  • Table 61. North America Peripheral Blood Sales by Application (2023-2028) & (K Units)
  • Table 62. North America Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
  • Table 63. North America Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
  • Table 64. North America Peripheral Blood Sales by Country (2017-2022) & (K Units)
  • Table 65. North America Peripheral Blood Sales by Country (2023-2028) & (K Units)
  • Table 66. North America Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
  • Table 67. North America Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
  • Table 68. Europe Peripheral Blood Sales by Company (2017-2022) & (K Units)
  • Table 69. Europe Peripheral Blood Sales Market Share by Company (2017-2022)
  • Table 70. Europe Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
  • Table 71. Europe Peripheral Blood Revenue Market Share by Company (2017-2022)
  • Table 72. Europe Peripheral Blood Sales by Type (2017-2022) & (K Units)
  • Table 73. Europe Peripheral Blood Sales by Type (2023-2028) & (K Units)
  • Table 74. Europe Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
  • Table 75. Europe Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
  • Table 76. Europe Peripheral Blood Sales by Application (2017-2022) & (K Units)
  • Table 77. Europe Peripheral Blood Sales by Application (2023-2028) & (K Units)
  • Table 78. Europe Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
  • Table 79. Europe Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
  • Table 80. Europe Peripheral Blood Sales by Country (2017-2022) & (K Units)
  • Table 81. Europe Peripheral Blood Sales by Country (2023-2028) & (K Units)
  • Table 82. Europe Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
  • Table 83. Europe Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
  • Table 84. Asia Pacific Peripheral Blood Sales by Company (2017-2022) & (K Units)
  • Table 85. Asia Pacific Peripheral Blood Sales Market Share by Company (2017-2022)
  • Table 86. Asia Pacific Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
  • Table 87. Asia Pacific Peripheral Blood Revenue Market Share by Company (2017-2022)
  • Table 88. Asia Pacific Peripheral Blood Sales by Type (2017-2022) & (K Units)
  • Table 89. Asia Pacific Peripheral Blood Sales by Type (2023-2028) & (K Units)
  • Table 90. Asia Pacific Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
  • Table 91. Asia Pacific Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
  • Table 92. Asia Pacific Peripheral Blood Sales by Application (2017-2022) & (K Units)
  • Table 93. Asia Pacific Peripheral Blood Sales by Application (2023-2028) & (K Units)
  • Table 94. Asia Pacific Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
  • Table 95. Asia Pacific Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
  • Table 96. Asia Pacific Peripheral Blood Sales by Region (2017-2022) & (K Units)
  • Table 97. Asia Pacific Peripheral Blood Sales by Region (2023-2028) & (K Units)
  • Table 98. Asia Pacific Peripheral Blood Revenue by Region (2017-2022) & (US$ Million)
  • Table 99. Asia Pacific Peripheral Blood Revenue by Region (2023-2028) & (US$ Million)
  • Table 100. Latin America Peripheral Blood Sales by Company (2017-2022) & (K Units)
  • Table 101. Latin America Peripheral Blood Sales Market Share by Company (2017-2022)
  • Table 102. Latin America Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
  • Table 103. Latin America Peripheral Blood Revenue Market Share by Company (2017-2022)
  • Table 104. Latin America Peripheral Blood Sales by Type (2017-2022) & (K Units)
  • Table 105. Latin America Peripheral Blood Sales by Type (2023-2028) & (K Units)
  • Table 106. Latin America Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
  • Table 107. Latin America Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
  • Table 108. Latin America Peripheral Blood Sales by Application (2017-2022) & (K Units)
  • Table 109. Latin America Peripheral Blood Sales by Application (2023-2028) & (K Units)
  • Table 110. Latin America Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
  • Table 111. Latin America Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
  • Table 112. Latin America Peripheral Blood Sales by Country (2017-2022) & (K Units)
  • Table 113. Latin America Peripheral Blood Sales by Country (2023-2028) & (K Units)
  • Table 114. Latin America Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
  • Table 115. Latin America Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
  • Table 116. Middle East and Africa Peripheral Blood Sales by Company (2017-2022) & (K Units)
  • Table 117. Middle East and Africa Peripheral Blood Sales Market Share by Company (2017-2022)
  • Table 118. Middle East and Africa Peripheral Blood Revenue by Company (2017-2022) & (US$ Million)
  • Table 119. Middle East and Africa Peripheral Blood Revenue Market Share by Company (2017-2022)
  • Table 120. Middle East and Africa Peripheral Blood Sales by Type (2017-2022) & (K Units)
  • Table 121. Middle East and Africa Peripheral Blood Sales by Type (2023-2028) & (K Units)
  • Table 122. Middle East and Africa Peripheral Blood Revenue by Type (2017-2022) & (US$ Million)
  • Table 123. Middle East and Africa Peripheral Blood Revenue by Type (2023-2028) & (US$ Million)
  • Table 124. Middle East and Africa Peripheral Blood Sales by Application (2017-2022) & (K Units)
  • Table 125. Middle East and Africa Peripheral Blood Sales by Application (2023-2028) & (K Units)
  • Table 126. Middle East and Africa Peripheral Blood Revenue by Application (2017-2022) & (US$ Million)
  • Table 127. Middle East and Africa Peripheral Blood Revenue by Application (2023-2028) & (US$ Million)
  • Table 128. Middle East and Africa Peripheral Blood Sales by Country (2017-2022) & (K Units)
  • Table 129. Middle East and Africa Peripheral Blood Sales by Country (2023-2028) & (K Units)
  • Table 130. Middle East and Africa Peripheral Blood Revenue by Country (2017-2022) & (US$ Million)
  • Table 131. Middle East and Africa Peripheral Blood Revenue by Country (2023-2028) & (US$ Million)
  • Table 132. HemaCare Corporation Information
  • Table 133. HemaCare Description and Overview
  • Table 134. HemaCare Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 135. HemaCare Peripheral Blood Product and Services
  • Table 136. HemaCare Peripheral Blood SWOT Analysis
  • Table 137. HemaCare Recent Developments
  • Table 138. StemExpress Corporation Information
  • Table 139. StemExpress Description and Overview
  • Table 140. StemExpress Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 141. StemExpress Peripheral Blood Product and Services
  • Table 142. StemExpress Peripheral Blood SWOT Analysis
  • Table 143. StemExpress Recent Developments
  • Table 144. AllCells Corporation Information
  • Table 145. AllCells Description and Overview
  • Table 146. AllCells Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 147. AllCells Peripheral Blood Product and Services
  • Table 148. AllCells Peripheral Blood SWOT Analysis
  • Table 149. AllCells Recent Developments
  • Table 150. Mozobil Corporation Information
  • Table 151. Mozobil Description and Overview
  • Table 152. Mozobil Peripheral Blood Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
  • Table 153. Mozobil Peripheral Blood Product and Services
  • Table 154. Mozobil Peripheral Blood SWOT Analysis
  • Table 155. Mozobil Recent Developments
  • Table 156. Key Raw Materials Lists
  • Table 157. Raw Materials Key Suppliers Lists
  • Table 158. Peripheral Blood Distributors List
  • Table 159. Peripheral Blood Customers List
  • Table 160. Research Programs/Design for This Report
  • Table 161. Key Data Information from Secondary Sources
  • Table 162. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Peripheral Blood Product Picture
  • Figure 2. Global Peripheral Blood Sales Market Share by Type in 2021 & 2028
  • Figure 3. Leukopak Product Picture
  • Figure 4. Stem Cells Product Picture
  • Figure 5. PBMCs Product Picture
  • Figure 6. Others Product Picture
  • Figure 7. Global Peripheral Blood Sales Market Share by Application in 2021 & 2028
  • Figure 8. Disease Treatment Use Case
  • Figure 9. Research and Development Use Case
  • Figure 10. Other Use Case
  • Figure 11. Peripheral Blood Report Years Considered
  • Figure 12. Global Peripheral Blood Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Peripheral Blood Market Size 2017-2028 (US$ Million)
  • Figure 14. Global Peripheral Blood Sales (2017-2022) & (K Units)
  • Figure 15. Global Peripheral Blood Market Size Market Share by Region: 2021 VS 2028
  • Figure 16. Global Peripheral Blood Sales Market Share by Region (2017-2022)
  • Figure 17. Global Peripheral Blood Sales Market Share by Region in 2021
  • Figure 18. Global Peripheral Blood Revenue Market Share by Region in 2017 VS 2021
  • Figure 19. Global Peripheral Blood Sales Share by Manufacturers in 2021
  • Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Peripheral Blood Sales in 2021
  • Figure 21. Peripheral Blood Revenue Share by Manufacturers in 2021
  • Figure 22. Peripheral Blood Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
  • Figure 23. Global Peripheral Blood Revenue Share by Type (2017-2022)
  • Figure 24. Global Peripheral Blood Revenue Growth Rate by Type in 2017 & 2021
  • Figure 25. Global Peripheral Blood Revenue Share by Application (2017-2022)
  • Figure 26. Global Peripheral Blood Revenue Growth Rate by Application in 2017 & 2021
  • Figure 27. North America Peripheral Blood Sales Market Share by Type (2017-2028)
  • Figure 28. North America Peripheral Blood Revenue Market Share by Type (2017-2028)
  • Figure 29. North America Peripheral Blood Sales Market Share by Application (2017-2028)
  • Figure 30. North America Peripheral Blood Revenue Market Share by Application (2017-2028)
  • Figure 31. North America Peripheral Blood Sales Share by Country (2017-2028)
  • Figure 32. North America Peripheral Blood Revenue Share by Country (2017-2028)
  • Figure 33. U.S. Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 34. Canada Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 35. Europe Peripheral Blood Sales Market Share by Type (2017-2028)
  • Figure 36. Europe Peripheral Blood Revenue Market Share by Type (2017-2028)
  • Figure 37. Europe Peripheral Blood Sales Market Share by Application (2017-2028)
  • Figure 38. Europe Peripheral Blood Revenue Market Share by Application (2017-2028)
  • Figure 39. Europe Peripheral Blood Sales Share by Country (2017-2028)
  • Figure 40. Europe Peripheral Blood Revenue Share by Country (2017-2028)
  • Figure 41. Germany Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 42. France Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 43. U.K. Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 44. Italy Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 45. Russia Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 46. Asia Pacific Peripheral Blood Sales Market Share by Type (2017-2028)
  • Figure 47. Asia Pacific Peripheral Blood Revenue Market Share by Type (2017-2028)
  • Figure 48. Asia Pacific Peripheral Blood Sales Market Share by Application (2017-2028)
  • Figure 49. Asia Pacific Peripheral Blood Revenue Market Share by Application (2017-2028)
  • Figure 50. Asia Pacific Peripheral Blood Sales Share by Region (2017-2028)
  • Figure 51. Asia Pacific Peripheral Blood Revenue Share by Region (2017-2028)
  • Figure 52. China Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 53. Japan Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 54. South Korea Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 55. India Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 56. Australia Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 57. Taiwan Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 58. Indonesia Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 59. Thailand Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 60. Malaysia Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 61. Philippines Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 62. Vietnam Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 63. Latin America Peripheral Blood Sales Market Share by Type (2017-2028)
  • Figure 64. Latin America Peripheral Blood Revenue Market Share by Type (2017-2028)
  • Figure 65. Latin America Peripheral Blood Sales Market Share by Application (2017-2028)
  • Figure 66. Latin America Peripheral Blood Revenue Market Share by Application (2017-2028)
  • Figure 67. Latin America Peripheral Blood Sales Share by Country (2017-2028)
  • Figure 68. Latin America Peripheral Blood Revenue Share by Country (2017-2028)
  • Figure 69. Mexico Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 70. Brazil Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 71. Argentina Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 72. Middle East and Africa Peripheral Blood Sales Market Share by Type (2017-2028)
  • Figure 73. Middle East and Africa Peripheral Blood Revenue Market Share by Type (2017-2028)
  • Figure 74. Middle East and Africa Peripheral Blood Sales Market Share by Application (2017-2028)
  • Figure 75. Middle East and Africa Peripheral Blood Revenue Market Share by Application (2017-2028)
  • Figure 76. Middle East and Africa Peripheral Blood Sales Share by Country (2017-2028)
  • Figure 77. Middle East and Africa Peripheral Blood Revenue Share by Country (2017-2028)
  • Figure 78. Turkey Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 79. Saudi Arabia Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 80. U.A.E Peripheral Blood Revenue (2017-2028) & (US$ Million)
  • Figure 81. Peripheral Blood Value Chain
  • Figure 82. Peripheral Blood Production Process
  • Figure 83. Channels of Distribution
  • Figure 84. Distributors Profiles
  • Figure 85. Bottom-up and Top-down Approaches for This Report
  • Figure 86. Data Triangulation
  • Figure 87. Key Executives Interviewed
目次

This research report focuses on the Peripheral Blood Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Market Segment by Type
    • 1.2.1 Global Peripheral Blood Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
    • 1.2.2 Leukopak
    • 1.2.3 Stem Cells
    • 1.2.4 PBMCs
    • 1.2.5 Others
  • 1.3 Market Segment by Application
    • 1.3.1 Global Peripheral Blood Market Share by Application (2017 VS 2021 VS 2028)
    • 1.3.2 Disease Treatment
    • 1.3.3 Research and Development
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Market Perspective

  • 2.1 Global Peripheral Blood Market Size (2017-2028)
    • 2.1.1 Global Peripheral Blood Revenue (2017-2028)
    • 2.1.2 Global Peripheral Blood Sales (2017-2028)
  • 2.2 Global Peripheral Blood Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
    • 2.2.1 Global Peripheral Blood Sales by Regions (2017-2022)
    • 2.2.2 Global Peripheral Blood Revenue by Regions (2017-2022)
  • 2.3 Global Peripheral Blood Market Size Forecast by Region
    • 2.3.1 Global Peripheral Blood Sales Forecast by Region (2023-2028)
    • 2.3.2 Global Peripheral Blood Revenue Forecast by Region (2023-2028)
  • 2.4 Global Top Peripheral Blood Regions (Countries) Ranking by Market Size
  • 2.5 Peripheral Blood Market Dynamics
    • 2.5.1 Peripheral Blood Market Trends
    • 2.5.2 Peripheral Blood Market Drivers
    • 2.5.3 Peripheral Blood Market Challenges
    • 2.5.4 Peripheral Blood Market Restraints

3 Competitive Landscape by Manufacturers

  • 3.1 Global Top Peripheral Blood Manufacturers by Sales (2017-2022)
    • 3.1.1 Global Peripheral Blood Sales by Manufacturers (2017-2022)
    • 3.1.2 Global Peripheral Blood Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global 5 and 10 Largest Manufacturers by Peripheral Blood Sales in 2021
  • 3.2 Global Top Manufacturers Peripheral Blood by Revenue
    • 3.2.1 Global Peripheral Blood Revenue by Manufacturers (2017-2022)
    • 3.2.2 Top Peripheral Blood Manufacturers Covered: Ranking by Revenue
    • 3.2.3 Global Peripheral Blood Revenue Share by Manufacturers (2017-2022)
    • 3.2.4 Global Peripheral Blood Market Concentration Ratio (CR5 and HHI)
  • 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Blood as of 2021)
  • 3.4 Global Peripheral Blood Average Selling Price (ASP) by Manufacturers
  • 3.5 Key Manufacturers Peripheral Blood Plants/Factories Distribution and Area Served
  • 3.6 Date of Key Manufacturers Enter into Peripheral Blood Market
  • 3.7 Key Manufacturers Peripheral Blood Product Offered
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Peripheral Blood Market Size by Type

  • 4.1 Global Peripheral Blood Historic Market Review by Type (2017-2022)
    • 4.1.1 Global Peripheral Blood Sales Market Share by Type (2017-2022)
    • 4.1.2 Global Peripheral Blood Revenue Market Share by Type (2017-2022)
    • 4.1.3 Peripheral Blood Price by Type (2017-2022)
  • 4.2 Global Peripheral Blood Market Estimates and Forecasts by Type (2023-2028)
    • 4.2.1 Global Peripheral Blood Sales Forecast by Type (2023-2028)
    • 4.2.2 Global Peripheral Blood Revenue Forecast by Type (2023-2028)
    • 4.2.3 Peripheral Blood Price Forecast by Type (2023-2028)

5 Global Peripheral Blood Market Size by Application

  • 5.1 Global Peripheral Blood Historic Market Review by Application (2017-2022)
    • 5.1.1 Global Peripheral Blood Sales Market Share by Application (2017-2022)
    • 5.1.2 Global Peripheral Blood Revenue Market Share by Application (2017-2022)
    • 5.1.3 Peripheral Blood Price by Application (2017-2022)
  • 5.2 Global Peripheral Blood Market Estimates and Forecasts by Application (2023-2028)
    • 5.2.1 Global Peripheral Blood Sales Forecast by Application (2023-2028)
    • 5.2.2 Global Peripheral Blood Revenue Forecast by Application (2023-2028)
    • 5.2.3 Peripheral Blood Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Peripheral Blood Sales Breakdown by Company
    • 6.1.1 North America Peripheral Blood Sales by Company (2017-2022)
    • 6.1.2 North America Peripheral Blood Revenue by Company (2017-2022)
  • 6.2 North America Peripheral Blood Market Size by Type
    • 6.2.1 North America Peripheral Blood Sales by Type (2017-2028)
    • 6.2.2 North America Peripheral Blood Revenue by Type (2017-2028)
  • 6.3 North America Peripheral Blood Market Size by Application
    • 6.3.1 North America Peripheral Blood Sales by Application (2017-2028)
    • 6.3.2 North America Peripheral Blood Revenue by Application (2017-2028)
  • 6.4 North America Peripheral Blood Market Size by Country
    • 6.4.1 North America Peripheral Blood Sales by Country (2017-2028)
    • 6.4.2 North America Peripheral Blood Revenue by Country (2017-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Peripheral Blood Sales Breakdown by Company
    • 7.1.1 Europe Peripheral Blood Sales by Company (2017-2022)
    • 7.1.2 Europe Peripheral Blood Revenue by Company (2017-2022)
  • 7.2 Europe Peripheral Blood Market Size by Type
    • 7.2.1 Europe Peripheral Blood Sales by Type (2017-2028)
    • 7.2.2 Europe Peripheral Blood Revenue by Type (2017-2028)
  • 7.3 Europe Peripheral Blood Market Size by Application
    • 7.3.1 Europe Peripheral Blood Sales by Application (2017-2028)
    • 7.3.2 Europe Peripheral Blood Revenue by Application (2017-2028)
  • 7.4 Europe Peripheral Blood Market Size by Country
    • 7.4.1 Europe Peripheral Blood Sales by Country (2017-2028)
    • 7.4.2 Europe Peripheral Blood Revenue by Country (2017-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Peripheral Blood Sales Breakdown by Company
    • 8.1.1 Asia Pacific Peripheral Blood Sales by Company (2017-2022)
    • 8.1.2 Asia Pacific Peripheral Blood Revenue by Company (2017-2022)
  • 8.2 Asia Pacific Peripheral Blood Market Size by Type
    • 8.2.1 Asia Pacific Peripheral Blood Sales by Type (2017-2028)
    • 8.2.2 Asia Pacific Peripheral Blood Revenue by Type (2017-2028)
  • 8.3 Asia Pacific Peripheral Blood Market Size by Application
    • 8.3.1 Asia Pacific Peripheral Blood Sales by Application (2017-2028)
    • 8.3.2 Asia Pacific Peripheral Blood Revenue by Application (2017-2028)
  • 8.4 Asia Pacific Peripheral Blood Market Size by Region
    • 8.4.1 Asia Pacific Peripheral Blood Sales by Region
    • 8.4.2 Asia Pacific Peripheral Blood Revenue by Region
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Taiwan
    • 8.4.9 Indonesia
    • 8.4.10 Thailand
    • 8.4.11 Malaysia
    • 8.4.12 Philippines
    • 8.4.13 Vietnam

9 Latin America

  • 9.1 Latin America Peripheral Blood Sales Breakdown by Company
    • 9.1.1 Latin America Peripheral Blood Sales by Company (2017-2022)
    • 9.1.2 Latin America Peripheral Blood Revenue by Company (2017-2022)
  • 9.2 Latin America Peripheral Blood Market Size by Type
    • 9.2.1 Latin America Peripheral Blood Sales by Type (2017-2028)
    • 9.2.2 Latin America Peripheral Blood Revenue by Type (2017-2028)
  • 9.3 Latin America Peripheral Blood Market Size by Application
    • 9.3.1 Latin America Peripheral Blood Sales by Application (2017-2028)
    • 9.3.2 Latin America Peripheral Blood Revenue by Application (2017-2028)
  • 9.4 Latin America Peripheral Blood Market Size by Country
    • 9.4.1 Latin America Peripheral Blood Sales by Country (2017-2028)
    • 9.4.2 Latin America Peripheral Blood Revenue by Country (2017-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil
    • 9.4.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Peripheral Blood Sales Breakdown by Company
    • 10.1.1 Middle East and Africa Peripheral Blood Sales by Company (2017-2022)
    • 10.1.2 Middle East and Africa Peripheral Blood Revenue by Company (2017-2022)
  • 10.2 Middle East and Africa Peripheral Blood Market Size by Type
    • 10.2.1 Middle East and Africa Peripheral Blood Sales by Type (2017-2028)
    • 10.2.2 Middle East and Africa Peripheral Blood Revenue by Type (2017-2028)
  • 10.3 Middle East and Africa Peripheral Blood Market Size by Application
    • 10.3.1 Middle East and Africa Peripheral Blood Sales by Application (2017-2028)
    • 10.3.2 Middle East and Africa Peripheral Blood Revenue by Application (2017-2028)
  • 10.4 Middle East and Africa Peripheral Blood Market Size by Country
    • 10.4.1 Middle East and Africa Peripheral Blood Sales by Country (2017-2028)
    • 10.4.2 Middle East and Africa Peripheral Blood Revenue by Country (2017-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 U.A.E

11 Company Profiles

  • 11.1 HemaCare
    • 11.1.1 HemaCare Corporation Information
    • 11.1.2 HemaCare Overview
    • 11.1.3 HemaCare Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.1.4 HemaCare Peripheral Blood Products and Services
    • 11.1.5 HemaCare Peripheral Blood SWOT Analysis
    • 11.1.6 HemaCare Recent Developments
  • 11.2 StemExpress
    • 11.2.1 StemExpress Corporation Information
    • 11.2.2 StemExpress Overview
    • 11.2.3 StemExpress Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.2.4 StemExpress Peripheral Blood Products and Services
    • 11.2.5 StemExpress Peripheral Blood SWOT Analysis
    • 11.2.6 StemExpress Recent Developments
  • 11.3 AllCells
    • 11.3.1 AllCells Corporation Information
    • 11.3.2 AllCells Overview
    • 11.3.3 AllCells Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.3.4 AllCells Peripheral Blood Products and Services
    • 11.3.5 AllCells Peripheral Blood SWOT Analysis
    • 11.3.6 AllCells Recent Developments
  • 11.4 Mozobil
    • 11.4.1 Mozobil Corporation Information
    • 11.4.2 Mozobil Overview
    • 11.4.3 Mozobil Peripheral Blood Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
    • 11.4.4 Mozobil Peripheral Blood Products and Services
    • 11.4.5 Mozobil Peripheral Blood SWOT Analysis
    • 11.4.6 Mozobil Recent Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Peripheral Blood Value Chain Analysis
  • 12.2 Peripheral Blood Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Peripheral Blood Production Mode & Process
  • 12.4 Peripheral Blood Sales and Marketing
    • 12.4.1 Peripheral Blood Sales Channels
    • 12.4.2 Peripheral Blood Distributors
  • 12.5 Peripheral Blood Customers

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Author Details
  • 14.3 Disclaimer